Guohui Cui - Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

基本信息

Career Trajectory

Bio

中国抗癌协会血液肿瘤专业委员会中国慢性淋巴细胞白血病工作组委员，中国医师协会血液科医师分会组织细胞疾病专业委员会委员，武汉市医学会血液病专业委员会委员

从事血液病基础与临床研究工作30余年，对常见及疑难血液病的诊治具有丰富的经验，尤其擅长对各种淋巴瘤、慢性淋巴细胞白血病的诊治，是淋巴瘤亚专科的负责人。主持国家自然科学基金、国家教委、湖北省自然科学基金重点项目等课题4项，以第一作者在国内外重要期刊发表论文30余篇。

Research Interests

Papers共 107 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Molecular Heterogeneity of CD30+ Peripheral T-cell Lymphoma with Prognostic Significance and Therapeutic Implications: a Retrospective Multi-Centre Study

Yu-Jia Huo,Shu Cheng,Hong-Mei Yi,Ting Niu,Lei Fan,Guo-Hui Cui,Fu-Ling Zhou,Xian-Min Song,Fei Li,Ou Bai,Xiao-Jing Yan,Jun Shi,Ming-Ci Cai,Yao-Hui Huang,Lei Dong,Jie Xiong, Song Hu, Yu-Ran Qiu,Yan Zhao, Peng-Peng Xu,Li Wang,Min Lu,Hong-Mei Jing,Wei-Li Zhao

EBioMedicine (2025): 105693-105693

Cited0Views0WOSBibtex

Extranodal Diffuse Large B-cell Lymphoma: Clinical and Molecular Insights with Survival Outcomes from the Multicenter EXPECT Study

Si-Yuan Chen, Peng-Peng Xu,Ru Feng,Guo-Hui Cui,Li Wang,Shu Cheng, Rong-Ji Mu,Hui-Lai Zhang,Xiao-Lei Wei,Yong-Ping Song,Kai-Yang Ding,Li-Hua Dong,Zun-Min Zhu,Shen-Miao Yang,Xin Wang,Ting-Bo Liu,Jian-Da Hu,Xiao-Yun Zheng,Ou Bai,Jing-Yan Xu,Liang Huang,Wei Sang,Ke-Qian Shi,Fan Zhou,Fei Li,Ai-Bin Liang,Hui Zhou,Si-Guo Hao,Hong-Hui Huang,Bin Xu,Wen-Bin Qian, Cai-Xia Li,Zhi-Ming Li,Chong-Yang Wu, Xiao-Bo Wang,Wen-Yu Shi,Shu-Ye Wang, Yu-Yang Tian,Xi Zhang,Ke-Shu Zhou, Li-Juan Cui,Hui Liu,Huo Tan,Qing Leng,Dong-Lu Zhao,Ting Niu,Wei-Li Zhao

Cancer communications (London, England) (2025)

Cited0Views0WOSBibtex

Zanubrutinib Plus R-CHOP Improves the Treatment Effect of Newly Diagnosed Diffuse Large B Cell Lymphoma with Double Expression of MYC and BCL-2

Min Zhang,Yingying Wu,Zhipeng Cheng,Lu Zhang,Lin Liu,Fang Liu,Guohui Cui,Linghui Xia,Yu Hu,Heng Mei,Tao Guo,Jun Fang

Frontiers in immunology (2025): 1526318-1526318

Cited0Views0WOSBibtex

Dynamic Change in Epstein-Barr Virus DNA Predicts Prognosis in Early Stage Natural Killer/t-Cell Lymphoma with Pegaspargase-Based Treatment: Long-Term Follow-Up and Biomarker Analysis from the NHL-004 Multicenter Randomized Study

Huijuan Zhong,Shu Cheng,Jie Xiong,Jiayi Chen, Rongji Mu, Haoxu Yang,Hongmei Yi,Qi Song,Hao Zhang,Yu Hu,Guohui Cui,Juying Wei,Xi Zhang,Bing Xu,Wenbin Qian,Xiaobing Huang,Ming Hou,Feng Yan,Xin Wang,Yongping Song,Yuanhua Liu,Xuejun Ma,Jianda Hu,Fei Li,Chongyang Wu, Junmin Chen,Li Yu,Ou Bai,Jingyan Xu,Zunmin Zhu,Li Liu,Xin Zhou, Li Huang,Yin Tong,Ting Niu,Depei Wu,Xufeng Jiang,Chaofu Wang,Binshen Ouyang,Gang Cai,Biao Li,Jia Liu,Zhifeng Li, Rong Xiao,Luqun Wang,Yujie Jiang,Yanyan Liu,Xiaoyun Zheng, Pengpeng Xu,Li Wang,Saijuan Chen,Wei-Li Zhao

Haematologica (2025)

Cited0Views0WOSBibtex

Targeted Agents Plus CHOP Compared with CHOP As the First-Line Treatment for Newly Diagnosed Patients with Peripheral T-Cell Lymphoma (GUIDANCE-03): an Open-Label, Multicentre Phase 2 Clinical Trial

Ming-Ci Cai,Shu Cheng,Hong-Mei Jing,Yan Liu,Guo-Hui Cui,Ting Niu,Jian-Zhen Shen,Liang Huang,Xin Wang,Yao-Hui Huang,Li Wang,Peng-Peng Xu,Wei-Li Zhao

LANCET REGIONAL HEALTH-WESTERN PACIFIC (2024)

Cited0Views0WOSBibtex

Efficacy and Safety of Single-Dose Versus Split-Dose Mecapegfilgrastim with Etoposide for Autologous Peripheral Blood Stem Cell Mobilization: A Prospective, Randomized Clinical Trial

Ao Zhang, Yingying Wu,Chunyan Sun,Fang Liu,Tao Guo,Guohui Cui,Heng Mei,Jing He,Min Zhang,Chun Zhang,Qiuling Wu, Wenjun He, Zhipeng Chen, Fei Zhao,Lin Liu, Bo Zhang,Lu Zhang,Danying Liao,Yu Hu,Linghui Xia,Jun Fang

BLOOD (2024): 4855-4856

Cited0Views0Bibtex

Phase 1/2 Studies of DZD8586, a Non-Covalent BBB Penetrant LYN/BTK Dual Inhibitor, in BTK Inhibitor Resistant Chronic Lymphocytic Leukemia (CLL) and Other B-Cell Non-Hodgkin Lymphoma (B-NHL)

Yuqin Song,Keshu Zhou,Hongmei Jing,Geoffrey Chong, Jianqiu Wu, Wei Liu,Zengjun Li,Ming Jiang, Mei Lan,Kaiyang Ding,Guohui CUI, Tingyu Wang,Xutao Guo,Sujun Gao, Constantine S. Tam, Haiyan Yang,Fang Zhu,Wei Yang,Jian-Qing Mi, Liping Su, Ke Fang, Ziyi Liu,Lindsey Roeker,Chan Y. Cheah,Jianyong Li,Lu-Gui Qiu

Bloodno. Supplement 1 (2024): 3248-3248

Cited0Views0Bibtex

Chidamide Plus Prednisone, Cyclophosphamide, and Thalidomide for Relapsed or Refractory Peripheral T-cell Lymphoma: A Multicenter Phase II Trial

Jinhua Liang,Li Wang,Xiaodong Wang,Guohui Cui,Jianfeng Zhou,Tongyao Xing,Kaixin Du,Jingyan Xu,Luqun Wang,Rong Liang,Biyun Chen,Jian Cheng,Haorui Shen,Jianyong Li,Wei Xu

CHINESE MEDICAL JOURNAL（2024）

Cited1Views0WOSBibtex

A Prospective Clinical Study of Zanubrutinib Combined with R-CHOP Regimen in the Treatment of Newly Diagnosed Double Expression Diffuse Large B-Cell Lymphoma

Yingying Wu,Ao Zhang, Liling Zhang,Guohui Cui,Fang Liu,Zhichao Chen, Zhipeng Chen,Lu Zhang, Lin Liu, Wenjuan He,Yu Hu,Linghui Xia,Jun Fang

Bloodno. Supplement 1 (2024): 6501-6501

Cited0Views0Bibtex

Rocbrutinib, a New-Generation BTK Inhibitor, Demonstrates Safety and Efficacy in Relapsed/Refractory Non-GCB Diffuse Large B Cell Lymphoma

Yuqin Song,Qingqing Cai,Keshu Zhou,Ming Jiang,Zhengming Jin,Lei Zhang,Xiuhua Sun, Haiyan Yang,Lanfang Li,Kaiyang Ding,Junyuan Qi,Hongmei Jing,Wei Yang,Min Zhou,Jun Ma,Zhigang Peng,Wei Xu,Hui Zhou,Li Yu,Yuankai Shi,Guohui Cui, Zheng Wang, Nawei Liu,Yejiang Lou, Yue Shen, Yi Chen,Fenlai Tan,Jun Zhu

Bloodno. Supplement 1 (2024): 3119-3119

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn

Guohui Cui(崔国惠)

主任医师

Papers共 107 篇Author StatisticsCo-AuthorSimilar Experts